coronary heart disease
Conditions
Interventions
Experimental group:ASCVD system+ routine nursing
Control group:Conventional nursing
Sponsors
Zhejiang University School of Medicine Sir Run Run Shaw Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 75 years; 2.Patients meet the diagnostic criteria for atherosclerotic cardiovascular disease include; Acute coronary syndrome (ACS), history of myocardial infarction (MI), stable or unstable angina, coronary artery or other revascularization, ischemic stroke, transient ischemic attack, and peripheral vascular disease (PAD); 3.Patients who are prescribed to take statins for long-term control of blood lipid; 4.Ability to use smart phones without obstacles and have basic Chinese reading and writing ability and simple computing ability; 5.Informed and agreed to participate in this study, and willing to adhere to the doctor's instructions for follow-up.
Exclusion criteria
Exclusion criteria: 1.Patients meeting ultra-high-risk ASCVD criteria; 2.With one or more of the following coronary heart disease complications: Heart failure, ventricular tachycardia, degree II TYPE II and degree III ATrioventricular block, uncontrolled atrial tachycardia (including atrial tachycardia, atrial flutter, atrial fibrillation, etc.), mural thrombosis, ventricular aneurysm, cardiac papillary muscle dysfunction or rupture, severe sinus bradycardia (heart rate <50 beats/min) and sinus arrest, etc.; 3.A history of cardiac arrest or sudden death; 4.Complicated with acute non-cardiac diseases, such as infection, renal failure, hyperthyroidism, etc.; 5.Complicated with other serious cardiovascular diseases: moderate to severe stenosis of valvular heart disease, hypertrophic cardiomyopathy or other forms of outflow tract stenosis, acute myocarditis, pericarditis, active endocarditis, suspected or known ruptured aneurysm, acute pulmonary embolism, or pulmonary infarction death, etc.; 6.Vulnerable groups include people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, PI or researchers students/subordinates, research units, or sponsor staff, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference in mean low density lipoprotein cholesterin between the two groups was compared from 1 month to 6 months after enrollment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ratio of low density lipoprotein cholesterin < 70mg/dL at month 1/3/6;Ratio of low density lipoprotein cholesterin < 70mg/dL and total cholesterol < 500mg/dL;Decline in low density lipoprotein cholesterin from baseline, lipid variability, body mass index;10-year atherosclerosis cardiovascular disease risk at 3/6 months; | — |
Countries
China
Contacts
Public ContactZhang Wenbin
Zhejiang University School of Medicine Sir Run Run Shaw Hospital
Outcome results
None listed